Publication Name	World Journal of Gastroenterology
Manuscript ID	5968
Country	Italy

Received	2013-09-29 09:10
Peer-Review Started	2013-10-04 15:58
To Make the First Decision	2013-10-14 21:04
Return for Revision	2013-10-17 11:39
Revised
Second Decision	2014-01-20 17:39
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-01-20 18:24
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-03-25 11:49
Publish the Manuscript Online	2014-04-04 15:11

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Clinical management of inflammatory bowel disease in the organ recipient
Manuscript Source	Invited Manuscript
All Author List	Amedeo Indriolo and Paolo Ravelli
Funding Agency and Grant Number
Corresponding Author	Amedeo Indriolo, MD, Digestive Endoscopy Unit, Department of Gastroenterology, Papa Giovanni XXIII Hospital, Piazza OMS, 1, 24127 Bergamo,Italy. amedeo.indriolo@gmail.com
Key Words	Inflammatory bowel disease; Ulcerative colitis; Crohn’s disease; Primary sclerosing cholangitis; Liver transplantation; Heart transplantation; Renal transplantation; Anti-tumor necrosis factor alpha therapy
Core Tip	Inflammatory bowel disease (IBD) in the organ transplant recipient population is an important clinical situation which is associated to higher morbidity and difficulty in the medical therapeutic management because of possible interaction between anti-reject therapy and IBD therapy. IBD course after liver transplantation is variable, but about one third of patients may worsen, needing an increase in medical therapy or a colectomy. About 30% of patients develop multiple IBD recurrence and 20% of patients require colectomy after renal transplantation. Like in the liver transplantation, anti-tumor necrosis factor alpha therapy could be an effective treatment in IBD patients with conventional refractory therapy after renal or heart transplantation.
Publish Date	2014-04-04 15:11
Citation	Indriolo A, Ravelli P. Clinical management of inflammatory bowel disease in the organ recipient. World J Gastroenterol 2014; 20(13): 3525-3533
URL	http://www.wjgnet.com/1007-9327/full/v20/i13/3525.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i13.3525

Full Article (PDF)	WJG-20-3525.pdf
Full Article (Word)	WJG-20-3525.doc
Manuscript File	5968-Review.docx
Answering Reviewers	5968-Answering reviewers.pdf
Copyright License Agreement	5968-Copyright assignment.pdf
Peer-review Report	5968-Peer reviews.pdf
Scientific Editor Work List	5968-Scientific editor work list.doc